This site is part of the Siconnects Division of Sciinov Group
This site is operated by a business or businesses owned by Sciinov Group and all copyright resides with them.
ADD THESE DATES TO YOUR E-DIARY OR GOOGLE CALENDAR
December 18, 2025
Northwestern Medicine researchers have uncovered a crucial link between transcription regulation and aging, revealing how specific molecular “traffic controllers” inside cells influence cellular senescence the state in which cells stop dividing but remain metabolically active. Published in Molecular Cell, the study explains how the finely tuned process of transcribing DNA into RNA plays a central role in age-related cellular changes.
The team focused on transcription elongation factors, proteins that help RNA polymerase II move along DNA to produce messenger RNA. Using advanced genetic tools and high-resolution RNA sequencing, they identified two key factors, NELF and SPT6, as major regulators of senescence. Prolonged depletion of these factors caused cells to temporarily stop growing and activate senescence-associated genes, yet this arrest was reversible, suggesting that senescence can be modulated by adjusting transcriptional machinery.
Further investigation highlighted another elongation factor, Elongin A (ELOA), which controls how transcription ends at genes and preferentially regulates short, stress-responsive genes. Loss of ELOA disrupted this process and surprisingly gave aging human fibroblasts a growth advantage, indicating that ELOA may act as a molecular brake on cell proliferation during aging. The findings also draw attention to ELOA3, a primate-specific homolog with natural genetic variation that may influence susceptibility to age-related diseases.
Overall, the study reveals that transcription elongation is a previously underappreciated but central mechanism in aging biology. By understanding how these factors shape senescence-associated gene programs, researchers see new opportunities to regulate aging processes and develop strategies to promote healthy aging and combat age-related diseases.